Dupixent® (Dupilumab) Recommended For EU Approval By The CHM…
(MENAFN- PR Newswire) Recommendation is based on data from two pivotal trials showing Dupixent significantly improved itch, skin lesions and health-related quality of life in […]
(MENAFN- PR Newswire) Recommendation is based on data from two pivotal trials showing Dupixent significantly improved itch, skin lesions and health-related quality of life in […]
Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis Recommendation is based on data from two pivotal trials showing […]
(MENAFN- PR Newswire) Recommendation based on a Phase 3 Libtayo trial that was first and only to demonstrate significantly improved survival compared to chemotherapy in […]
Recommendation based on a Phase 3 Libtayo trial that was first and only to demonstrate significantly improved survival compared to chemotherapy in the second-line setting […]
(MENAFN- PR Newswire) Dupixent significantly reduced itch and skin lesions compared to placebo in direct-to-Phase 3 program consisting of two pivotal trials About 75,000 adults […]
Dupixent significantly reduced itch and skin lesions compared to placebo in direct-to-Phase 3 program consisting of two pivotal trials About 75,000 adults in the U.S. […]
(MENAFN- PR Newswire) Dupixent is the first and only biologic that significantly improved skin clearance, and reduced itch and overall disease severity in children as […]
Future-proofing Technology Innovations to Significantly Improve Fixed and Mobile Wireless Access Technology Performance Airgain, Inc. (NASDAQ: AIRG), a global provider of wireless connectivity solutions, including […]
(MENAFN- ValueWalk) 3844328 / Pixabay Charter Communications (NASDAQ:CHTR) is a significantly undervalued stock today. But are competition, 5G, and satellite internet significant threats to […]
Exclusive: Satellite broadcaster on verge of securing rights to critically acclaimed US drama Fans of stylish US drama Mad Men will have to pay to […]